Elaine Lee, MD
Surgical Oncology · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 28
- 8 carriers
- Offices
- 3
Offices
3 locations · Bay Area Gynecology Oncology Inc · Epic Care · Hazel Hawkins Memorial Hospital
Hospitals listed: Alta Bates Summit Medical Center · Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
28 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lee’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
28 of 28 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A128258 · Current
Licensed to practise in California · since 2013 · expires 2027-11-30 · Ohio State University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$93,529
Medicare paid this office $93,529 for 282 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 226 | $29,580 | $111 |
| Partial removal of breast | 20 | $13,746 | $598 |
| Mri scan of both breasts | 22 | $8,669 | $361 |
| Limited ultrasound scan of 1 breast | 41 | $4,983 | $87 |
| Long return visit (40+ min) | 21 | $4,317 | $149 |
See all 13 services
| Return visit (30+ min) | 226 | $29,580 | $111 |
| Partial removal of breast | 20 | $13,746 | $598 |
| Mri scan of both breasts | 22 | $8,669 | $361 |
| Limited ultrasound scan of 1 breast | 41 | $4,983 | $87 |
| Long return visit (40+ min) | 21 | $4,317 | $149 |
| Biopsy or removal of deep lymph nodes of underarm | 17 | $3,923 | $231 |
| New patient visit (60+ min) | 20 | $3,720 | $186 |
| New patient visit (45+ min) | 24 | $3,395 | $141 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $2,236 | $118 |
| Imaging of lymph nodes during surgery | 17 | $2,148 | $126 |
| Ultrasonic guidance during surgery | 21 | $858 | $41 |
| Injection, gadobutrol, 0.1 ml | 22 | $473 | $0 |
| X-ray of surgical specimen | 21 | $365 | $14 |
Procedures Medicare counted
| Mastectomy | 1-10 | None |
| Melanoma (skin cancer) excision | 1-10 | None |
Who their Medicare patients are
282 Original Medicare patients in 2024. Average age 74 · Under 65 7% · 85 and older 9% · Also on Medicaid 33% · Health risk score 1.03. At or below the middle of the specialty; the typical surgical oncology clinician is at 1.48.
Conditions among them: Cancer 75% · High blood pressure 70% · Diabetes 31% · Chronic kidney disease 17% · Depression 17% · Coronary heart disease 11% · COPD 8% · Atrial fibrillation 8% · Stroke 7% · Heart failure 6% · Dementia 5%.
The office billed $388,551, Medicare allowed $125,836 and paid $93,529; for 2,534 services of 35 kinds; $477 of it was for drugs given in the office and $93,053 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 282 | 2,534 | 74 | 1.03 | $388,551 | $93,529 |
| 2023 | 242 | 4,236 | 73 | 1.00 | $449,637 | $120,077 |
| 2022 | 241 | 2,702 | 73 | 1.05 | $494,983 | $105,829 |
| 2021 | 111 | 1,395 | 72 | 0.92 | $200,651 | $46,533 |
| 2020 | 34 | 44 | 72 | 0.77 | $15,960 | $5,269 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Return visit (30+ min) | 186 | $25,289 | $107 |
| Mri scan of both breasts | 36 | $14,189 | $373 |
| Partial removal of breast | 20 | $12,108 | $550 |
| Limited ultrasound scan of 1 breast | 43 | $5,916 | $87 |
| New patient visit (60+ min) | 29 | $5,844 | $202 |
| Long return visit (40+ min) | 22 | $5,339 | $148 |
| Biopsy or removal of deep lymph nodes of underarm | 19 | $4,018 | $211 |
| Repair of wound of trunk by transferring skin, 10.0 sq cm or less | 12 | $3,724 | $286 |
| Telephone medical discussion with physician, 21-30 minutes | 25 | $2,747 | $89 |
| New patient visit (45+ min) | 19 | $2,438 | $128 |
| Imaging of lymph nodes during surgery | 19 | $2,229 | $117 |
| Ultrasonic guidance during surgery | 22 | $1,131 | $51 |
| Injection, gadobutrol, 0.1 ml | 37 | $944 | $0 |
| X-ray of surgical specimen | 22 | $346 | $14 |
2022: 15 services
| Return visit (30+ min) | 180 | $21,977 | $99 |
| Partial removal of breast | 18 | $9,966 | $525 |
| Mri scan of both breasts | 22 | $8,588 | $373 |
| Limited ultrasound scan of 1 breast | 61 | $7,416 | $80 |
| Long return visit (40+ min) | 24 | $6,017 | $163 |
| Repair of wound of trunk by transferring skin, 10.0 sq cm or less | 16 | $4,969 | $276 |
| New patient visit (45+ min) | 36 | $4,407 | $122 |
| New patient visit (60+ min) | 22 | $4,082 | $186 |
| Biopsy or removal of deep lymph nodes of underarm | 16 | $3,358 | $210 |
| Telephone medical discussion with physician, 21-30 minutes | 23 | $2,175 | $84 |
| Imaging of lymph nodes during surgery | 16 | $1,874 | $117 |
| Ultrasonic guidance during surgery | 21 | $1,158 | $53 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 17 | $962 | $51 |
| Injection, gadobutrol, 0.1 ml | 22 | $538 | $0 |
| X-ray of surgical specimen | 21 | $330 | $14 |
2021: 6 services
| Return visit (30+ min) | 77 | $11,421 | $112 |
| Mri scan of both breasts | 13 | $5,137 | $395 |
| Limited ultrasound scan of 1 breast | 37 | $3,936 | $89 |
| Long return visit (40+ min) | 20 | $3,407 | $162 |
| New patient visit (45+ min) | 14 | $2,155 | $154 |
| Injection, gadobutrol, 0.1 ml | 14 | $341 | $0 |
2020: 2 services
| Return visit (30+ min) | 11 | $1,282 | $99 |
| Short return visit (20+ min) | 11 | $783 | $65 |
Medicaid work
$14,605 in 2024
Medicaid paid $14,605 for 263 billed services this clinician did in 2024, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 215 | $12,109 |
| Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited | 48 | $2,496 |
| 2024 | 263 | 2 | 26 | $14,605 |
| 2023 | 159 | 1 | 24 | $7,445 |
| 2022 | 197 | 2 | 27 | $10,991 |
| 2021 | 65 | 2 | 14 | $2,629 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 159 | $7,445 |
2022
| Return visit (30+ min) | 145 | $8,505 |
| Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited | 52 | $2,485 |
2021
| Return visit (30+ min) | 39 | $1,609 |
| Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited | 26 | $1,020 |
Drugs they prescribed that Part D paid
$215
Pharmacies billed $215 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 80% of their Part D prescriptions (32 of 40) in 2024. Too few prescriptions to compare fairly with other clinicians.
40 generic and 0 brand-name prescriptions · $215 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycodone | 26 | $69 | $2 |
Year by year
| 2024 | 40 | 33 | 80% (32) | 0% | $215 |
| 2023 | 50 | 40 | 66% (33) | None | $140 |
| 2022 | 45 | 34 | 69% (31) | 0% | $158 |
| 2021 | 24 | 19 | 54% (13) | 0% | $75 |
| 2020 | 20 | 16 | None | None | $471 |
| 2017 | 14 | None | None | 0% | $106 |
| 2016 | 26 | 22 | 62% (16) | 0% | $804 |
| 2015 | 17 | 11 | None | None | $260 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Oxycodone | 30 | $75 | $2 |
| Lorazepam | 13 | $12 | $1 |
2022: 1 drug
| Oxycodone | 29 | $88 | $3 |
2021: 1 drug
| Oxycodone | 11 | $25 | $2 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 14 | $108 | $8 |
Money from drug and device companies
$645 in 2025
| 2025 | 14 | 19 | None | $645 |
| 2024 | 14 | 20 | None | $566 |
| 2023 | 20 | 44 | None | $1,668 |
| 2022 | 24 | 35 | None | $939 |
| 2021 | 10 | 17 | None | $405 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Merck Sharp & Dohme | Keytruda | $145 | 3 payments
|
| Eisai | Lenvima | $89 | 3 payments
|
| Smith+Nephew | Stravix | $85 | 2 payments
|
| Dilon Technologies | Hemoblast Bellows | $71 | 1 payment
|
| Novartis Pharmaceuticals | Kisqali | $33 | 1 payment
|
| Coherus Oncology | Loqtorzi | $33 | 1 payment
|
See all 19 published payments
| Smith+Nephew | Meals · 2025-08-22 | Grafix | $37 |
| Smith+Nephew | Meals · 2025-07-30 | Stravix | $48 |
| Eisai | Meals · 2025-07-07 | Lenvima | $32 |
| Elucent Medical | Meals · 2025-06-09 | None | $17 |
| Eisai | Meals · 2025-05-27 | Lenvima | $26 |
| Eisai | Meals · 2025-05-05 | Lenvima | $31 |
| Merck Sharp & Dohme | Meals · 2025-05-02 | Keytruda | $91 |
| Vertex Pharmaceuticals | Meals · 2025-04-29 | Journavx | $25 |
| Biotissue Holdings | Meals · 2025-04-17 | None | $18 |
| Dilon Technologies | Meals · 2025-04-16 | Hemoblast Bellows | $71 |
| Abbvie | Meals · 2025-02-13 | Epkinly | $28 |
| Novartis Pharmaceuticals | Meals · 2025-01-29 | Kisqali | $33 |
| Merck Sharp & Dohme | Meals · 2025-01-29 | Keytruda | $21 |
| TerSera Therapeutics | Meals · 2025-01-27 | Zoladex | $25 |
| Coherus Oncology | Meals · 2025-01-26 | Loqtorzi | $33 |
| Merck Sharp & Dohme | Meals · 2025-01-22 | Keytruda | $33 |
| Daiichi Sankyo | Meals · 2025-01-17 | Enhertu | $30 |
| BeiGene USA | Meals · 2025-01-15 | Brukinsa | $24 |
| Incyte | Meals · 2025-01-13 | Monjuvi | $23 |
See earlier years (2024, 2023, 2022, 2021)
2024: $566
| AstraZeneca Pharmaceuticals LP | Enhertu | $156 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Alunbrig | $71 | 3 payments
|
| Merck Sharp & Dohme | Keytruda | $57 | 2 payments
|
| Janssen Biotech | Erleada | $55 | 2 payments
|
| Regeneron Healthcare Solutions | Libtayo | $32 | 1 payment
|
| Pfizer | Padcev | $26 | 1 payment
|
| Agios Pharmaceuticals | Pyrukynd | $25 | 1 payment
|
| Abbvie | Epkinly | $23 | 1 payment
|
| EMD Serono | None | $22 | 1 payment
|
| Recordati Rare Diseases Inc. | Sylvant | $22 | 1 payment
|
| Daiichi Sankyo | Enhertu | $21 | 1 payment
|
| Deciphera Pharmaceuticals | Qinlock | $21 | 1 payment
|
| Cardinal Health 414 | Kit for the Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) | $20 | 1 payment
|
| Incyte | Jakafi | $15 | 1 payment
|
2023: $1,668
| Myriad Genetic Laboratories | Prolaris | $338 | 6 payments
|
| Leica Microsystems | None | $190 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $189 | 4 payments
|
| Janssen Biotech | Imbruvica | $163 | 8 payments
|
| Medical Device Business Services | Vistaseal | $138 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $114 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $103 | 4 payments
|
| Amgen | Blincyto | $69 | 3 payments
|
| Genentech USA | Venclexta | $55 | 2 payments
|
| Lilly USA | Jaypirca | $44 | 2 payments
|
| KUB Technologies | Mozart | $41 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $38 | 2 payments
|
| Ethicon US | Dermabond Prineo | $33 | 1 payment
|
| Avanos Medical | On-Q* Pump and Accessories | $28 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Nubeqa | $25 | 1 payment
|
| Taiho Oncology | Lonsurf | $24 | 1 payment
|
| Seagen | Padcev | $23 | 1 payment
|
| Deciphera Pharmaceuticals | Qinlock | $21 | 1 payment
|
| Incyte | Jakafi | $20 | 1 payment
|
| Rigel Pharmaceuticals | Rezlidhia | $11 | 1 payment
|
2022: $939
| Seagen | Padcev | $127 | 5 payments
|
| Trevena | Olinvyk | $97 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Tagrisso | $81 | 4 payments
|
| Endomagnetics | Magseed | $67 | 1 payment
|
| Bioptics | Biozorb | $53 | 1 payment
|
| Amgen | Kyprolis | $48 | 2 payments
|
| Novartis Pharmaceuticals | Mekinist | $44 | 2 payments
|
| Pharmacyclics LLC an AbbVie | Imbruvica | $44 | 2 payments
|
| Dendreon Pharmaceuticals | Provenge | $33 | 1 payment
|
| Genzyme | Jevtana | $33 | 1 payment
|
| Taiho Oncology | Lonsurf | $33 | 2 payments
|
| GlaxoSmithKline | Blenrep | $30 | 1 payment
|
| Mylan Institutional | None | $28 | 1 payment
|
| Myovant Sciences | Orgovyx | $28 | 1 payment
|
| EMD Serono | None | $25 | 1 payment
|
| Sobi | Doptelet | $23 | 1 payment
|
| Daiichi Sankyo | Injectafer | $23 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $22 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Xofigo | $21 | 1 payment
|
| Rigel Pharmaceuticals | Tavalisse | $19 | 1 payment
|
| Blue Earth Diagnostics | Axumin | $17 | 1 payment
|
| Kyowa Kirin | Poteligeo | $16 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $14 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $13 | 1 payment
|
2021: $405
| Amgen | Kyprolis | $85 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $69 | 3 payments
|
| Merck Sharp & Dohme | Keytruda | $60 | 3 payments
|
| Novartis Pharmaceuticals | Lutathera | $47 | 2 payments
|
| Regeneron Healthcare Solutions | Libtayo | $28 | 1 payment
|
| Janssen Biotech | Darzalex | $27 | 1 payment
|
| Acceleron Pharma | Reblozyl | $25 | 1 payment
|
| Seagen | Tukysa | $24 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Xofigo | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $21 | 1 payment
|
Professional record
- NPI
- 1619243086
- Licence
- CA A128258California A128258: Current · expires 2027-11-30
- Trained
- Ohio State University College of Medicine, 2012
- Group
- Bay Area Gynecology Oncology Inc · Epic Care · Hazel Hawkins Memorial Hospital
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Surgery (208600000X)
- Mailing address
- 910 Campisi Way Ste 2a, Campbell, CA, 95008
- NPI first listed
- 2012-03-29
- NPI last updated
- 2025-08-20
- NPI record certified
- 2025-08-20
This is when the NPI record was last certified, not a medical board exam.